Medicamen Biotech Ltd Share Price

₹382.10 -4.75 (-1.23%) BSE
as updated on 24-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:380.75
  • Day's High:386.05

  • 52 Week Low292.50
  • 52 Week High565.10

Medicamen Biotech Ltd's key Fundamentals

Market Cap ₹525 Cr.
P/E Ratio 59.8
TTM EPS 6.5
P/B Ratio 1.98
ROE 4.19
Debt to Equity 0.13
Face Value 10
BVPS 195.7
3 Year Sales Growth 9.47%

Medicamen Biotech Ltd's Share Price Returns

1 Day -1.23%
1 Week -3.30%
1 Month -4.70%
3 Months 17.50%
6 Months -8.00%
1 Years -26.50%
3 Years -51.10%
5 Years -3.70%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Medicamen Biotech Ltd Shareholding Pattern

Promoters

(40.46%)

Institutions

(0.70%)

Non-Institutions

(58.85%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Medicamen Biotech Ltd

Medicamen Biotech Limited was incorporated in December 1993, it is a widely held, Globaly Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. Medicamen Biotech Limited is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical fraternity since inception.

Medicamen Biotech started its operation as distributor and manufacturer of medicines on loan license basis. The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries.The vast distribution network with demand for low cost medicines prompted Mr. B.K. Gupta - Managing Director of the company to go for own manufacturing facilities. Thus in the later part of 1994 a land of 2,10,000 square feet in the Industrial town of Bhiwadi in the state of Rajasthan was procured.

In 1995 Medicamen Biotech Limited was enlisted in Bombay Stock Exchange and public issue was oversubscribed by more than 11 times. Within a span of 10 years Medicamen Biotech Limited is now among top 50 Indian export company.

In the year 2005 keeping the pace with the ever increasing demand and fulfilling the commitment, a second unit was installed in the Tax free zone at Haridwar in the state of Uttarakhand .The Unit II is fully operational from April 2007 with ultra modern manufacturing facilities.

Product range of the company includes:

The company is the Manufacturer and supplier of Comprehensive range of products:

  • Tablets
  • Capsules
  • Liquid Syrup
  • Dry Syrup (Beta Lactum and Non Beta Lactum)
  • Ointment
  • ORS

Achievements/ recognition:

The company is the receipents of the following certificates & awards:

  • WHO-GMP
  • ISO 9001: 2000
  • Star Export House
  • Certificate Of Merit
  • “Niryat Shree” for the four consecutive years from 2002 to 2005 from Government of India
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 380.75
  • Day's High: 386.05

  • 52 Week Low292.50
  • 52 Week High565.10

Medicamen Biotech Ltd's key Fundamentals

Market Cap ₹525 Cr.
P/E Ratio 59.8
TTM EPS 6.5
P/B Ratio 1.98
ROE 4.19
Debt to Equity 0.13
Face Value 10
BVPS 195.7
3 Year Sales Growth 9.47%

Medicamen Biotech Ltd's Share Price Returns

1 Day -1.23%
1 Week -3.30%
1 Month -4.70%
3 Months 17.50%
6 Months -8.00%
1 Years -26.50%
3 Years -51.10%
5 Years -3.70%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×